Ferrara Robert L's Form 4 filing
Phio Pharmaceuticals Corp. (PHIO) · filed Jun 15, 2023
- Accession no.
- 0001209191-23-037408
- Filed
- Jun 15, 2023
- Trade date
- Jun 14, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $6.20K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ferrara Robert LCIK 0001792987 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2023 | Common stock, $0.0001 par value | PPurchaseAcquired | +2,000 | $3.10 | +$6,200 | 6,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.